News Quantified

PHGE – biomx inc. common stock (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

BiomX Inc. Announces 1-for-19 Reverse Stock Split

BiomX Inc (PHGE) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]

BiomX outlines imminent FDA feedback and targets BX004 Phase IIb data in Q1 2026 while advancing BX011 for diabetic foot infections [Seeking Alpha]

BiomX Inc. (PHGE) Q3 2025 Earnings Call Transcript [Seeking Alpha]

-8.7%

BEAT

-8.2%

BEAT

2.6%

BEAT

Form 8-K BiomX Inc. For: Nov 25

Form 8-K BiomX Inc. For: Nov 17

Form 10-Q BiomX Inc. For: Sep 30

Form 8-K BiomX Inc. For: Nov 12

Form 8-K BiomX Inc. For: Oct 17

Top News Gainers

12/19 Chardan Acts as M&A Advisor in Health Sciences Acquisitions Corporation Completed Merger with Immunovant 12.2%

12/30 Form 4 BiomX Inc. For: Dec 20 Filed by: GROSSMAN JONAS 10.8%

4/25 BiomX Inc. (NASDAQ: PHGE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.5%

3/26 BiomX Reports Full Year 2019 Financial Results and Provides Business Update 7.4%

2/17 BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference 3.9%

3/27 Form 4 BiomX Inc. For: Mar 25 Filed by: Wolfson Marina 3.1%

12/12 Form 4 BiomX Inc. For: Dec 10 Filed by: OrbiMed Israel GP Ltd. 2.3%

3/20 BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting 2.2%

12/2 BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin 1.8%

1/15 Form 3 BiomX Inc. For: Jan 15 Filed by: Wolfson Marina 1.7%

Top News Decliners

3/31 BiomX Announces Positive Topline Data from Phase 1 Study for Lead Candidate BX001 for Acne-Prone Skin -9.3%

11/7 Form 3 BiomX Inc. For: Oct 28 Filed by: Woodman Robbie -8.3%

11/12 Form 3 BiomX Inc. For: Nov 04 Filed by: Sullivan Lynne Marie -5.7%

11/12 Stone Street Group Initiates Coverage On BiomX Inc. -5.5%

11/5 Form 3 BiomX Inc. For: Oct 28 Filed by: TAKEDA PHARMACEUTICAL CO LTD -3.9%

11/1 Form 8-K BiomX Inc. For: Oct 28 -3.2%

1/8 BiomX Inc. (NASDAQ: PHGE) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. -3.2%

11/20 Form 4 BiomX Inc. For: Nov 18 Filed by: GROSSMAN JONAS -3.0%

2/3 BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange -2.8%

11/4 BiomX Appoints Russell G. Greig, Ph.D, as Chairman of the Board of Directors and Lynne Sullivan as Board Director -2.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day